COMMUNIQUÉS West-GlobeNewswire

Sen-Jam Pharmaceutical Underscores the Urgent Need to Revolutionize Pain Management and End the Opioid Epidemic at the 2019 StartUp Health Festival

13/02/2019 - 14:00

HUNTINGTON, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Sen-Jam Pharmaceutical , a therapeutic company focused on bringing relief to the opioid crisis, was delighted to present at the 2019 StartUp Health Festival, the [...]

Inovalon to Present at Morgan Stanley Technology, Media & Telecom Conference

13/02/2019 - 13:55

BOWIE, Md., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D [...]

VIVUS to Host Fourth Quarter and Full Year Business Update and Financial Results Conference Call on Tuesday, February 26, 2019

13/02/2019 - 13:30

CAMPBELL, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the fourth quarter and full year of 2018 after the [...]

PSI Ramps Up its Executive Leadership Team

13/02/2019 - 13:30

New Roles Align the Company to Long-Term Strategy of Improving the Delivery of Healthcare ARLINGTON, Va., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI), a leading provider of Health IT [...]

Auxly Bolsters Management Team

13/02/2019 - 13:00

VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce the appointments of Brian Schmitt as Chief Financial Officer, [...]

Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole for C. Difficile Infection

13/02/2019 - 13:00

Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole for C. Difficile Infection Trials Aim to Show Superiority of Ridinilazole [...]

Emerald Health Therapeutics Announces Completion of Pure Sunfarms CAD$20 Million Credit Facility with Bank of Montreal and Farm Credit Canada

13/02/2019 - 13:00

VICTORIA, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high- [...]

XOMA Receives $5.5 Million Payment from Rezolute

13/02/2019 - 13:00

EMERYVILLE, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today it has received a $5.5 million payment from Rezolute, Inc., related to the Companies’ 2017 license agreement, as most [...]

ContraFect Announces Oral Presentation at the 2019 Gordon Research Conference on Mechanisms and Application: Realizing the Potential of Antimicrobial Host Defense Peptides for Human and Veterinary Medicine

13/02/2019 - 13:00

YONKERS, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]

Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations

13/02/2019 - 13:00

Issuance of new patents strengthens the intellectual property around Melt Pharmaceuticals’ flagship drug candidate and potential label extensions SAN DIEGO and BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Melt [...]

Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results

13/02/2019 - 13:00

Reports record fourth quarter revenue of $141.0 million Reports fourth quarter GAAP loss per share of $0.35 and non-GAAP earnings per share of $0.43 Provides annual revenue and earnings guidance for 2019 PLEASANTON, [...]

Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference

13/02/2019 - 13:00

VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: BTH ) (FRANKFURT: BTI) (OTCQB: BTHCF ) (the “ Company [...]

Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results

13/02/2019 - 12:40

- Acquired Avista Pharma Solutions, broadening capabilities, enhancing revenue growth and expanding customer base - - Conference call at 8:30 a.m. ET on February 13, 2019 - EAST RUTHERFORD, N.J., Feb. 13, 2019 (GLOBE [...]

Natus Medical Announces Continued Board Refreshment with Two New Independent Directors

13/02/2019 - 12:30

PLEASANTON, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) announced today a significant refreshment of its board of directors with the appointment of Alice D. Schroeder, former CEO [...]

AroCell's CEO share his views on the company in a video interview

13/02/2019 - 12:00

Today AroCell publishes a short video interview with Michael Brobjer, CEO, and his reflections on his first months at Arocell. The video is available through the link below, AroCell website, and on Financial Hearings [...]

Sensorion to Present New SENS-401 Data at ARO 2019 MidWinter Meeting, Feb. 9-13, 2019

13/02/2019 - 07:30

Two poster presentations to show growing evidence base for SENS-401 in inner ear disease MONTPELLIER, France, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN / PEA-PME eligible) , a biotech company [...]

PCI Biotech: Fourth quarter and preliminary 2018 results

13/02/2019 - 07:30

Oslo (Norway), 13 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim fourth quarter and preliminary 2018 result. Please find enclosed the report and [...]

ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology

13/02/2019 - 06:15

Discovery could open doorway to new treatment SHEFFIELD, United Kingdom and HAYWARD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Researchers at the University of Sheffield have identified a new pathway that is disrupted [...]

MacroGenics Announces Pricing of Public Offering of Common Stock

13/02/2019 - 03:25

ROCKVILLE, MD, Feb. 12, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]